started · updated
Hospital 12 de Octubre study identifies safest analgesics for critical newborns
A study conducted by the Pharmacy Service of the Hospital 12 de Octubre in Madrid has analyzed the use of analgesics and sedatives in critical newborns for the first time. The research, performed in collaboration with the Neonatology Service, the i+12 Research Institute, and the Complutense University of Madrid, observed 357 neonates in the Neonatal Intensive Care Unit over a 13-month period.
The findings, published in ‘Anales de Pediatría’, establish paracetamol and fentanyl as the safest first-line analgesic options, with fentanyl being the preferred choice when opioids are required. For sedation, dexmedetomidine was identified as a primary option. The study also highlights the intranasal route as a less invasive administration method.
Data showed that 53.2% of patients required sedation or analgesia, with a median therapy duration of 4.5 days. The need for these drugs increases significantly among neonates requiring mechanical ventilation, affecting 92.7% of that group compared to 35.9% of non-ventilated infants. The researchers emphasized the necessity of standardized protocols and electronic prescription systems to ensure patient safety.
Entities
Complutense University of Madrid · Hospital 12 de Octubre · Madrid · i+12 Research Institute